Kyntra Bio KYNB
NASDAQ KYNB
$3.30 -0.19 (-5.44%)
As of: Nov 16, 2026 · 11:49 AM EST

Kyntra Bio (KYNB) EV to EBIT (2019)

Updated

Kyntra Bio's (KYNB) EV to EBIT stood at 84.26 in Q3 2019, up 5.6% from the prior quarter.

Analysis

Kyntra Bio (KYNB) EV to EBIT (2019) Analysis & Trends

On a TTM basis, Kyntra Bio's EV to EBIT came in at 24.75 as of Sep 30, 2019.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,292.38 Bn 1,265.99 Bn 20.46 Bn
2 Johnson & Johnson 685.50 Bn 605.36 Bn 17.30 Bn
3 AbbVie 526.37 Bn 494.37 Bn 13.12 Bn
4 Merck 362.03 Bn 324.97 Bn 13.19 Bn
5 Novartis Ag 313.25 Bn 286.48 Bn -
6 Astrazeneca 286.56 Bn 260.08 Bn 13.26 Bn
7 Amgen 253.40 Bn 205.05 Bn 7.58 Bn
8 Gilead Sciences 210.31 Bn 185.42 Bn 6.73 Bn
9 Pfizer 165.24 Bn 112.60 Bn 12.56 Bn
10 Kyntra Bio 13.32 Mn -394.63 Mn 1.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 84.26
Jun 30, 2019 79.81
API Access

Kyntra Bio EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=KYNB&period=max&api_key=YOUR_API_KEY